Sanofi-Aventis' New R&D Model Aims To Build A Network For Innovation

Anticipated reorganization seems to mimic previous actions by Big Pharma, with an emphasis on external collaboration and a move to smaller, independent groups..

More from Archive

More from Pink Sheet